With a Focus on Anti-Aging, This Emerging Biotech Company is Working to Create Shareholder Value!

[This Biotech Company Has the Potential to Dominate Any and All Regulatory Drug Development for Delaying Aging and Prolonging Healthy Lifespan!]( Many of the biggest killers in the modern world, from cancer to heart disease to dementia, affect older people far more often than younger ones. Rather than tackle these individual problems one at a time, why not go after the ageing process that causes them? That's what this emerging biotech company is doing and has an opportunity to transform major health sectors across the medical landscape! TNF inhibitors are drugs that help stop inflammation in the body. An example would be Humira, which pulled in $19.83B in revenue! One of this company's potential drug candidates has shown effectiveness in regulating the immune system in pre-clinical studies. They have received Investigational New Drug (IND) clearance from the FDA to move forward with a phase 2 trial, and efficacy data is expected by the end of the first quarter of 2022. To their knowledge, theirs is the only IND application for a Phase 2 trial of a patented drug related to delaying aging. [Discover how this company believes it has the resources to fund a significant runway for drug research and development!]( The Team @Dear Wall Street 11138 Del Amo Blvd. #359 Lakewood, CA 90715 --------------------------------------------------------------- DISCLAIMERS - THIS IS A PAID ADVERTISEMENT. This is a paid advertisement, not a recommendation nor an offer to buy or sell securities or investments. Our business model is to be financially compensated to market and promote public companies. By reading this email, our website / media webpage you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis for making investment decisions and is strictly for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor's, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our website / media webpage. IRPub LLC has received Ten Thousand five Hundred Dollars paid by a third party, Interactive Offers, for and on behalf of MyMD Pharmaceuticals (NASDAQ: MYMD) for brand awareness, marketing distribution and investor education marketing for a period of 2 Days. IR Pub has not received any shares nor owns any shares of MyMD Pharmaceuticals (NASDAQ: MYMD For a full disclaimer | disclosure please [click here.]( This communication is a paid advertisement and is not a recommendation to buy or sell securities or investments. IR PUB Network, and its owners, managers, employees, and assigns (collectively "the Company") has been paid by the profiled company or a third party to disseminate this communication. In this case the Company has been paid by a third party, Interactive Offers for and on behalf of MyMD Pharmaceuticals (NASDAQ: MYMD)Ten Thousand Five Hundred Dollars for marketing services for a period of 2 days. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our Websites, Email, SMS, Push Notifications, Influencers, Social Media Postings, Ticker Tags, Press Releases, Online Interviews, Podcasts, Videos, Audio Ads, Banner Ads, Native Ads, Responsive Ads. This compensation is a major conflict with our ability to be unbiased, more specifically: This communication is strictly for entertainment purposes only. Never invest purely based on our communication. Gains mentioned in this article, in our newsletter and on our website may be based on end-of-day or intraday data. We have been compensated by a third party, Interactive Offers, for and on behalf of MyMD Pharmaceuticals (NASDAQ: MYMD)to conduct investor awareness advertising and marketing. Therefore, this communication should be viewed as a commercial advertisement only. The information is collected from public sources, such as the profiled company's website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, IR PUB Network often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers' works are double-checked and verified before publication, and approved by the company that is featured herein, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer's communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. We have not thoroughly investigated the background of ARGYF. The third party, profiled company, or their affiliates may liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to impact share prices. Frequently companies profiled in our alerts experience a large fluctuation in volume and share price during the course of investor awareness marketing, which often end as soon as the investor awareness marketing ceases. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our communications and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company's website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. NOT AN INVESTMENT ADVISOR. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing the Company, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions. RISK OF INVESTING. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website / media webpage are strictly for entertainment purposes only. Never invest purely based on our featured profiles on Companies. Gains mentioned in our website / media webpage may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities or investments mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. The past performance of any trading system or methodology is not necessarily indicative of future results. The profits and performance shown are not typical, we make no future earnings claims, and you may lose money. All trades, patterns, charts, systems, etc., discussed in this message and the product materials are strictly for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher. --------------------------------------------------------------- This email is a paid advertisement. It is for a product and/or service that is not offered, recommended or endorsed by Tips4Traders and neither the company nor its affiliates bear responsibility or control over the content of the advertisement and the product or service offered. There is a very high degree of risk involved in trading. Past performance is not indicative of future results. The profits and performance shown are not typical, we make no future earnings claims, and you may lose money. Tips4Traders and all individuals affiliated with this site assume no responsibility for your trading and investment results. The indicators, strategies, columns, articles and all other features are strictly for communication purposes only and should not be construed as investment advice. Information for any trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. Your information may be shared with our educational partners. You must assess the risk of any trade with your licensed investment professional and make your own independent decisions regarding any securities or investments mentioned herein. Affiliates of Tips4Traders may have a position or effect transactions in the securities or investments described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies. --------------------------------------------------------------- This email was sent to {EMAIL} by Tips4Traders 495 Town Plaza Ave | | Ponte Vedra | FL | 32081 [Forward to a friend]( | [Unsubscribe](